CD43

From WikiMD's WELLNESSPEDIA

CD43, also known as sialophorin, is a glycoprotein that is predominantly expressed on the surface of various immune cells, including T cells, B cells, macrophages, and granulocytes. This protein plays a crucial role in the modulation of cell adhesion and immune response mechanisms.

Structure[edit]

CD43 is characterized by a large, heavily glycosylated extracellular domain, a transmembrane region, and a short cytoplasmic tail. The extensive glycosylation of the extracellular domain, which consists mostly of sialic acid residues, is critical for its function and interaction with other cellular components.

Function[edit]

The primary function of CD43 is to regulate cell-cell interactions within the immune system. It acts as an anti-adhesion molecule, meaning it generally inhibits the binding of cells to one another, facilitating the free movement of immune cells through the bloodstream and into tissues. This anti-adhesive property is crucial during the immune response, particularly in the migration of T cells to sites of infection or inflammation.

CD43 also transmits intracellular signals that can influence cell activation, proliferation, and differentiation. The cytoplasmic tail of CD43 interacts with various signaling molecules and plays a role in the activation pathways of T cells and other immune cells.

Clinical Significance[edit]

Alterations in the expression or function of CD43 have been implicated in several diseases. In cancer, CD43 expression can be altered in leukemia cells, affecting the behavior and survival of these cells. Additionally, because of its role in immune cell trafficking, CD43 has been studied in the context of autoimmune diseases, where improper immune cell activation and migration are common features.

Research[edit]

Ongoing research is focused on understanding the detailed mechanisms by which CD43 regulates immune responses and its potential as a therapeutic target in diseases involving the immune system. Studies are also exploring the role of CD43 in tumor progression and metastasis, given its function in cell movement and interaction.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.